A prospective pilot clinical trial conducted by neurotologists and neurologists in Spain has found that chronic electrical stimulation delivered through an implantable vestibular prosthesis is associated with substantial improvements in motor performance, dynamic balance, and postural stability among patients suffering from both Parkinson’s disease and bilateral vestibular hypofunction. The investigation, carried out between 2018 and 2024 at the Complejo Hospitalario Universitario Insular Materno-Infantil in Las Palmas de Gran Canaria, assessed whether targeted peripheral stimulation of residual otolithic nerve fibers could modulate dysfunctional sensorimotor circuits in the central nervous system. Over a twelve-month follow-up period following surgical device activation, three patients diagnosed with concomitant Parkinson’s disease and bilateral vestibulopathy demonstrated clinically meaningful motor enhancements alongside a matched reference cohort of three individuals with isolated bilateral vestibulopathy. By combining standardized clinical motor examinations, comprehensive audiovestibular profiling, computerized posturography, and functional molecular neuroimaging, the exploratory research provides early proof-of-concept evidence that peripheral sensory interfaces can engage ascending motor networks that frequently prove refractory to conventional oral dopaminergic replacement therapies.
The therapeutic rationale behind vestibular neuromodulation stems from an evolving understanding of Parkinson’s disease as an extensive disorder of distributed sensorimotor integration rather than a localized pathology restricted entirely to the degeneration of substantia nigra dopaminergic neurons. While levodopa and other pharmacological agents remain the primary clinical treatment for cardinal motor symptoms, axial manifestations such as gait impairment, freezing of gait, and severe postural instability routinely fail to respond satisfactorily as neurodegeneration progresses. Postural equilibrium and locomotion depend on continuous physiological integration across basal ganglia, brainstem, cerebellar, thalamic, and cerebral cortical pathways. Anatomical research indicates that the peripheral vestibular system supplies continuous graviceptive and accelerative signals into these subcortical circuits through direct vestibulo-thalamo-striatal projections and ascending brainstem pathways. Because previous epidemiological evaluations have documented vestibular abnormalities or vestibulo-ocular reflex impairments in roughly thirty-nine to forty-four percent of studied Parkinson’s populations, delivering direct electrical stimulation to peripheral vestibular afferents offers an alternative avenue to drive physiological inputs into disrupted motor coordination networks.
The study protocol was approved by the local institutional ethics committee under references CEIm-CHUIMI 956 and CEIm 2023-134-1, conforming strictly to the ethical standards of the Helsinki Declaration. Eligible adult participants met the definitive diagnostic criteria established by the Bárány Society for bilateral vestibulopathy lasting at least one year with insufficient response to six months of vestibular rehabilitation. Functional candidate criteria required absent cervical and ocular vestibular evoked myogenic potentials in the ear selected for surgery, paired with computerized tomography and magnetic resonance imaging confirming a patent vestibule and intact vestibular nerve. From an auditory perspective, candidates exhibited moderate to severe-to-profound hearing loss in the surgical ear, as determined by pure-tone audiometry and disyllabic speech recognition scoring. Exclusion criteria were rigorous, screening out individuals with inner ear ossification, middle ear disease, persistent postural-perceptual dizziness, central oculomotor pathology, peripheral neuropathy, active psychiatric conditions, and recent participation in competing investigational trials.
The six enrolled participants were distributed evenly across two clinical cohorts, comprising three men with isolated bilateral vestibulopathy and three men presenting with concomitant bilateral vestibulopathy and established Parkinson’s disease. Baseline demographic analysis showed no statistically significant differences between the two groups regarding chronological age or vestibular hypofunction duration. Within the Parkinson’s subgroup, participants exhibited established motor disability corresponding to Hoehn and Yahr stages ranging between 1.5 and 3.0, deliberately selected to study moderate motor involvement while excluding both mild unilateral disease and late-stage immobile states. Patient 1 was a 56-year-old male presenting with a six-year history of Parkinson’s disease at Hoehn and Yahr stage 3 and a one-year evolution of postinfectious vestibular loss. Patient 2 was a 49-year-old male with a three-year history of Parkinson’s at stage 1.5 and a nineteen-year history of postinfectious vestibulopathy. Patient 3 was a 67-year-old male with a four-year history of Parkinson’s at stage 2 alongside a ten-year duration of vestibulopathy secondary to Ménière’s disease.
Surgical intervention involved the implantation of a customized Cochlear CI24RE (ST) device equipped with a specialized straight electrode array incorporating three active electrical contacts dedicated entirely to vestibular stimulation. The surgical team positioned these full-band contacts in direct anatomical proximity to the saccular macula, aiming to maximize electrical field coverage over residual otolithic afferent nerve fibers without relying on damaged mechanical hair cell transduction. Otolithic neurostimulation was delivered as a continuous train of charge-balanced biphasic electrical pulses characterized by a pulse width of 25 microseconds per phase. Pulse stimulation frequencies were individualized between 900 and 1,200 pulses per second in a monopolar reference configuration utilizing extracochlear ball and plate electrodes. Current amplitudes across the three active contacts were adjusted according to intraoperative neural responses and postoperative perceptual thresholds to eliminate uncomfortable facial nerve stimulation, unsteadiness, or unintended acoustic sensations.
Following surgical implantation and device activation, all participants completed an individualized, structured vestibular rehabilitation regimen delivered by experienced physical therapists. The rehabilitation program comprised ten to fifteen supervised sessions conducted once or twice weekly, systematically targeting vestibulo-ocular reflex adaptation, gaze stabilization, postural control reweighting, and dynamic sensory substitution. Baseline evaluations were obtained within the two months preceding surgical implantation, while full post-activation assessments were repeated at one, two, three, six, and twelve months. To preserve analytical consistency between functional recovery and molecular neuroimaging, the researchers analyzed paired data collected at the final preoperative baseline and the terminal twelve-month postoperative evaluation. Standardized clinical batteries measured audiological thresholds, video head impulse reflex gains across all six semicircular canals, cervical and ocular myogenic potentials, computerized dynamic posturography, static subjective visual vertical alignment, and validated self-reported quality-of-life questionnaires.
Clinical motor performance in the Parkinson’s disease cohort was quantified using Part III of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale, administered by examining neurologists while all dopaminergic agonist medications were held to isolate device-mediated changes. All three participants with Parkinson’s disease exhibited notable reductions in motor disability twelve months after device activation, registering overall score decreases of 44, 20, and 28 points. Patient 1 dropped from a baseline motor score of 55 down to 11 points; Patient 2 declined from 29 to 9 points; and Patient 3 improved from 42 to 14 points. Domain-specific breakdowns demonstrated that the most robust improvements occurred within axial and bradykinetic symptoms, specifically gait fluidity, freezing of gait episodes, postural stability scores, chair-rising agility, and hand or foot tapping speed. In contrast, changes in rigidity and kinetic or resting tremor demonstrated greater variability among participants, reinforcing the observation that otolithic input preferentially modulates axial locomotor and postural circuitry rather than rhythmic tremulous loops.
Computerized dynamic posturography conducted through the Sensory Organization Test revealed distinct functional differences between cohorts alongside marked postoperative recovery. At baseline, participants with dual diagnoses exhibited compromised global equilibrium scores averaging 18.00 ± 4.58 points out of 100, which increased significantly to 49.00 ± 8.54 points after twelve months of continuous vestibular stimulation. Their somatosensory utilization ratio surged from an initial 87.00 ± 13.00 to a perfect 100.00 ± 0.00, and their visual ratio rose from 77.00 ± 2.65 to 95.33 ± 5.03. Interestingly, visual preference ratios in the Parkinson’s cohort remained at 8.33 ± 7.64 before and after implantation, contrasting sharply with the isolated vestibulopathy cohort, whose visual preference remained elevated at 96.67 ± 5.77 preoperatively and 91.67 ± 8.50 postoperatively. The authors noted that this persistent discrepancy reflects central sensory integration deficits inherent to Parkinson’s pathology, where patients struggle to exploit environmental visual anchors effectively, yet benefit substantially once artificial vestibular cues are restored to recalibrate internal equilibrium references.
Electrophysiological assessments documented that native acoustic cervical and ocular vestibular evoked myogenic potentials remained completely absent in all six implanted patients throughout the entire study duration, confirming irreversible destruction of physiological mechanotransduction. However, following electrical device activation, four out of the six patients demonstrated reproducible electrically evoked cervical vestibular potentials recorded from the sternocleidomastoid muscle, confirming that the implant successfully recruited viable descending vestibulospinal pathways. Subjective graviceptive vertical perception assessed through static subjective visual vertical testing improved markedly across both cohorts, with angular errors in the Parkinson’s group normalizing from 3.23 ± 1.70 degrees down to 1.23 ± 0.51 degrees, well within normal physiological boundaries of 2.3 degrees or less. Fall risk decreased substantially, eliminating recurrent falls in four of the six participants who reported regular falling at study entry. Furthermore, Dynamic Gait Index scores improved past the functional threshold of 20 points across all subjects, while Timed Up and Go mobility durations remained below the 12-second cutoff for fall vulnerability.
To investigate whether peripheral otolithic stimulation exerted downstream effects on basal ganglia neurochemistry, the investigators performed single-photon emission computed tomography neuroimaging with iodine-123-ioflupane at the twelve-month milestone. Patients underwent twin SPECT scans under standardized conditions: first during a temporary device deactivation lasting two hours to capture the OFF condition, followed the next day by a repeat scan under active continuous stimulation in the ON condition. Quantitative analysis of distribution volume ratios against age-calibrated normative databases demonstrated measurable elevations in presynaptic dopamine transporter availability during the ON stimulation state in all three Parkinson’s patients. Striatal binding ratios increased bilaterally, exhibiting a distinct trend toward greater percentage gains in the hemisphere contralateral to the implanted ear. In Patient 1, striatal distribution volume ratios increased from 3.21 to 3.50 ipsilaterally and from 2.98 to 3.49 contralaterally, reaching normative reference intervals. Patient 2 and Patient 3 exhibited similar upward shifts, though their absolute binding remained below age-adjusted healthy benchmarks.
The study authors emphasize that these molecular neuroimaging and motor findings must be interpreted with deliberate scientific caution due to several fundamental methodological limitations. As an early phase I pilot investigation, the sample size was restricted to six individuals, precluding confirmatory inferential statistics, population-level generalizations, or the identification of reliable predictive biomarkers. Furthermore, the absence of an unoperated sham-stimulation control group prevents researchers from disentangling true electrophysiological neuromodulation from expectation bias, placebo mechanisms, repetitive test familiarity, and the physical benefits of supervised vestibular rehabilitation. The authors also explicitly noted that fluctuations in striatal distribution volume ratios reflect changes in dopamine transporter availability and functional network states rather than structural nigrostriatal neurogenesis or direct dopamine release. Nevertheless, these preliminary findings demonstrate that chronic peripheral vestibular neurostimulation is surgically feasible, well-tolerated, and capable of driving functional motor and sensorimotor network improvements in patients facing neurodegenerative motor decline.
Subject of Research: Chronic vestibular implant stimulation for motor and balance deficits in Parkinson's disease with bilateral vestibulopathy
Article Title: Vestibular implant as a novel peripheral neuromodulation strategy for complex movement disorders. A pilot study in patients with Parkinson’s disease associated with bilateral vestibular dysfunction
Article References: Lorente-Piera, J., Santana, A. S., de Miguel, Á. R., Borkoski-Barreiro, S., González, J. C. F., Monedero, J., Miranda Ramos, J., Sanfiel Delgado, A., Manrique-Huarte, R., Manrique, M., Sluydts, M., & Ramos Macías, Á. (2026). Vestibular implant as a novel peripheral neuromodulation strategy for complex movement disorders. A pilot study in patients with Parkinson’s disease associated with bilateral vestibular dysfunction. Frontiers in Neurology, 17, Article 1953762. https://doi.org/10.3389/fneur.2026.1953762
Image Credits: AI Generated
DOI: 10.3389/fneur.2026.1953762
Keywords: Parkinson's disease, vestibular implant, bilateral vestibulopathy, neuromodulation, deep brain stimulation, MDS-UPDRS III, postural stability, gait impairment, freezing of gait, sensory organization test, subjective visual vertical, DaTSCAN, dopamine transporter, otolith stimulation, vestibular evoked myogenic potentials, dynamic gait index, neurodegenerative disorders
News Source: Cassandra Pierce. (November 16, 2026). Vestibular Implants Improve Motor Function in Pilot Parkinson’s Disease Trial. Scienmag.



